What is ‘Scromiting’? ER Doctors Are Seeing it More

Cannabis legalization has advanced faster than public understanding of how today’s products differ from those used decades ago. The rise of cannabinoid hyperemesis syndrome complicates the familiar divide between harmless normalization and prohibition-era alarm. Greenwood’s reporting matters because it treats an emerging health signal seriously while keeping uncertainty visible, a balance essential when policy, commercial potency, and medical knowledge change at different speeds.nnThe diagnostic challenge is central. CHS resembles cyclic vomiting syndrome, including repeated nausea, abdominal pain, and episodes that disappear for stretches of time. Hot bathing may offer relief, but that behavior also appears among some patients who never used cannabis, so it is not a simple test. Recognition depends on careful histories of frequency, duration, and THC exposure rather than a dramatic nickname or a single symptom.nnPotency changes the risk conversation. Dried cannabis that once contained low single-digit THC percentages may now exceed fifteen per cent, while concentrates can reach far higher levels. Yet many heavy users never develop CHS, and some patients began cannabis to manage other conditions. Those facts make causation, predisposition, and communication difficult, but they do not remove the practical pattern that symptoms often recede when cannabis use stops.nnWe picked this explainer because it gives patients and clinicians language for a condition that can otherwise produce repeated emergency visits and confusion. Readers who use cannabis, care for someone who does, or follow drug policy should understand both the warning signs and the limits of current evidence. The piece also avoids turning a colloquial term into spectacle by noting that clinicians may regard it as derogatory.That nuance matters for public health messaging, which must warn frequent users clearly without treating every patient as reckless or every exposure as equivalent. As legal markets make stronger products ordinary, how many “new” illnesses are actually old risks becoming easier to see?